Cavutilide (Refralon) for pharmacological cardioversion of early recurrence atrial fibrillation and flutter in blanking period after pulmonary veins isolation

Cavutilide (Refralon) for pharmacological cardioversion of early recurrence atrial fibrillation and flutter in blanking period after pulmonary veins isolation

Objective. Evaluate efficacy and safety of cavutilide (Refralon) for pharmacological cardioversion in patients with recurrent atrial fibrillation and flutter (AF/AFL), in 90days blanking period of catheter ablation.Materials and methods. included 56 patients: 46 patients with recurrent paroxysmal AF...

Full description

Bibliographic Details
Main Authors: M. A. Zelberg, N. Yu. Mironov, Kh. M. Dzaurova, Yu. A. Yuricheva, E. B. Maykov, P. S. Novikov, D. A. Gagloeva, M. A. Krimukova, S. F. Sokolov, S. P. Golitsyn
Format: Article
Language:Russian
Published: InterMedservice 2024-05-01
Series:Евразийский Кардиологический Журнал
Subjects:
atrial fibrillation
atrial flutter
cardioversion
catheter ablation
recurrence
cavutilide
refralon
Online Access:https://www.heartj.asia/jour/article/view/6459

Internet

https://www.heartj.asia/jour/article/view/6459

Similar Items